AI MARKET SCANNING

Crinetics Pharmaceuticals Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -0.09%
MAX GAP RECORD -7.89%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $CRNX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 04, 2026 Earnings Release 2026-08-04 (AFTER CLOSE)
+0.00%
May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE)
-0.97%
Feb 26, 2026 Earnings Release 2026-02-26 (AFTER CLOSE)
+3.16%
Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE)
-7.89%
Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE)
-0.54%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
-0.64%
Feb 27, 2025 Earnings Release 2025-02-27 (AFTER CLOSE)
+2.20%
Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE)
+2.08%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.6%
Bullish Gaps (6)
Bearish Gaps (4)
Neutral / Flat (4)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $CRNX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The firm's product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. It is also developing other oral nonpeptide…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗